Alzheimer medication
FDA approves Alzheimer’s medication that delayed cognitive decline in clinical trials
Lecanemab, a treatment for Alzheimer's disease, received an expedited approval from the Food and Drug Administration on Friday. This is…
Lecanemab, a treatment for Alzheimer's disease, received an expedited approval from the Food and Drug Administration on Friday. This is…
You can control the ways in which we improve and personalize your experience. Please choose whether you wish to allow the following: